BIONET Therapeutics Corp. (TPEX:7808)
Taiwan · Delayed Price · Currency is TWD 30.80
-1.30 (-4.05%)
At close: Aug 28, 2026
BIONET Therapeutics Market Cap
BIONET Therapeutics has a market cap or net worth of 2.26 billion as of August 28, 2026. Its market cap has decreased by -36.19% in one year.
Market Cap
2.26B
Enterprise Value
1.26B
Revenue
196.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.80
ChartMarket Cap Chart
Since December 12, 2024, BIONET Therapeutics's market cap has decreased from 3.82B to 2.26B, a decrease of -40.64%. That is a compound annual growth rate of -26.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 2.26B | -42.44% |
| Dec 31, 2025 | 3.93B | 20.99% |
| Dec 31, 2024 | 3.25B | -14.77% |
| Dec 12, 2024 | 3.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 21.35B |
| Elixiron Immunotherapeutics (Cayman) Limited | 18.60B |
| Intelligene | 7.71B |
| Uwell Biopharma | 6.56B |
| Tripartite Therapeutics | 4.69B |
| Obigen Pharma | 3.86B |
| Pet Pharm Biotech | 3.38B |
| FullHope Biomedical | 1.40B |